Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(-30.0%)
USD 0.0
(-30.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -504.31 Million USD | -2.84% |
| 2021 | -368.04 Million USD | -82.63% |
| 2020 | -201.52 Million USD | -3.25% |
| 2019 | -195.18 Million USD | -50.75% |
| 2018 | -129.47 Million USD | -347.39% |
| 2017 | 52.33 Million USD | 187.38% |
| 2016 | -59.89 Million USD | 19.06% |
| 2015 | -74 Million USD | -113.01% |
| 2014 | -34.74 Million USD | -60.34% |
| 2013 | -21.66 Million USD | -346.52% |
| 2012 | -4.85 Million USD | -49.66% |
| 2011 | -3.24 Million USD | -78.93% |
| 2010 | -1.81 Million USD | -89.93% |
| 2009 | -954.12 Thousand USD | -400.81% |
| 2008 | -190.51 Thousand USD | 20.83% |
| 2007 | -240.63 Thousand USD | 45.22% |
| 2006 | -439.28 Thousand USD | -42.61% |
| 2005 | -308.03 Thousand USD | -40271.04% |
| 2004 | -763.00 USD | 0.0% |
| 2003 | -763.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -106.34 Million USD | -33.32% |
| 2023 Q2 | -77.23 Million USD | 27.37% |
| 2022 Q4 | -79.76 Million USD | 27.58% |
| 2022 Q3 | -110.14 Million USD | -19.88% |
| 2022 FY | -378.5 Million USD | -2.84% |
| 2022 Q2 | -91.88 Million USD | 14.04% |
| 2022 Q1 | -106.88 Million USD | -1.98% |
| 2021 Q1 | -84.9 Million USD | -20.39% |
| 2021 Q2 | -100.55 Million USD | -18.43% |
| 2021 Q3 | -90.26 Million USD | 10.23% |
| 2021 Q4 | -104.81 Million USD | -16.12% |
| 2021 FY | -368.04 Million USD | -82.63% |
| 2020 Q3 | -83.1 Million USD | -74.12% |
| 2020 FY | -201.52 Million USD | -3.25% |
| 2020 Q2 | -47.72 Million USD | -10.58% |
| 2020 Q1 | -43.16 Million USD | -32.49% |
| 2020 Q4 | -70.52 Million USD | 15.14% |
| 2019 Q2 | -50.36 Million USD | 59.11% |
| 2019 Q4 | -32.57 Million USD | 38.86% |
| 2019 FY | -195.18 Million USD | -50.75% |
| 2019 Q1 | -123.17 Million USD | -196.08% |
| 2019 Q3 | -53.28 Million USD | -5.8% |
| 2018 Q2 | -28.37 Million USD | 12.83% |
| 2018 Q4 | -41.6 Million USD | 13.17% |
| 2018 FY | -129.47 Million USD | -347.39% |
| 2018 Q1 | -32.54 Million USD | 6.47% |
| 2018 Q3 | -47.9 Million USD | -68.86% |
| 2017 Q3 | 96.91 Million USD | 820.14% |
| 2017 Q1 | -23.32 Million USD | -95.98% |
| 2017 FY | 52.33 Million USD | 187.38% |
| 2017 Q4 | -34.79 Million USD | -135.9% |
| 2017 Q2 | -13.45 Million USD | 42.3% |
| 2016 FY | -59.89 Million USD | 19.06% |
| 2016 Q2 | -46.35 Million USD | -87.26% |
| 2016 Q1 | -24.75 Million USD | -40.17% |
| 2016 Q3 | -13.76 Million USD | 70.3% |
| 2016 Q4 | -11.9 Million USD | 13.54% |
| 2015 Q2 | -10.53 Million USD | -3.5% |
| 2015 FY | -74 Million USD | -113.01% |
| 2015 Q3 | -35.63 Million USD | -238.32% |
| 2015 Q4 | -17.66 Million USD | 50.44% |
| 2015 Q1 | -10.17 Million USD | -4.42% |
| 2014 Q1 | -9.87 Million USD | 11.28% |
| 2014 FY | -34.74 Million USD | -60.34% |
| 2014 Q3 | -7.13 Million USD | 10.76% |
| 2014 Q2 | -7.99 Million USD | 19.07% |
| 2014 Q4 | -9.74 Million USD | -36.67% |
| 2013 Q3 | -3.3 Million USD | 29.89% |
| 2013 FY | -21.66 Million USD | -346.52% |
| 2013 Q1 | -2.51 Million USD | -43.12% |
| 2013 Q4 | -11.12 Million USD | -236.56% |
| 2013 Q2 | -4.71 Million USD | -87.61% |
| 2012 Q3 | -1.24 Million USD | -31.59% |
| 2012 FY | -4.85 Million USD | -49.66% |
| 2012 Q2 | -944.87 Thousand USD | -4.11% |
| 2012 Q1 | -907.59 Thousand USD | -18.9% |
| 2012 Q4 | -1.75 Million USD | -41.3% |
| 2011 Q1 | -686.08 Thousand USD | -263.5% |
| 2011 Q3 | -703.66 Thousand USD | 35.41% |
| 2011 FY | -3.24 Million USD | -78.93% |
| 2011 Q2 | -1.08 Million USD | -58.78% |
| 2011 Q4 | -763.32 Thousand USD | -8.48% |
| 2010 Q4 | -188.74 Thousand USD | 57.64% |
| 2010 Q1 | -601.39 Thousand USD | 12.93% |
| 2010 Q2 | -576.49 Thousand USD | 4.14% |
| 2010 Q3 | -445.54 Thousand USD | 22.72% |
| 2010 FY | -1.81 Million USD | -89.93% |
| 2009 Q3 | -238.66 Thousand USD | -199.16% |
| 2009 Q1 | -58.83 Thousand USD | -27.69% |
| 2009 FY | -954.12 Thousand USD | -400.81% |
| 2009 Q4 | -690.68 Thousand USD | -189.39% |
| 2009 Q2 | -79.77 Thousand USD | -35.59% |
| 2008 Q3 | -125.84 Thousand USD | -2215.83% |
| 2008 Q4 | -46.07 Thousand USD | 63.38% |
| 2008 Q2 | -5434.00 USD | 58.71% |
| 2008 Q1 | -13.16 Thousand USD | -77.41% |
| 2008 FY | -190.51 Thousand USD | 20.83% |
| 2007 Q3 | -10.64 Thousand USD | 15.64% |
| 2007 Q1 | -209.94 Thousand USD | 0.0% |
| 2007 FY | -240.63 Thousand USD | 45.22% |
| 2007 Q4 | -7418.00 USD | 30.32% |
| 2007 Q2 | -12.62 Thousand USD | 93.99% |
| 2006 FY | -439.28 Thousand USD | -42.61% |
| 2006 Q1 | - USD | 100.0% |
| 2005 Q3 | -191.00 USD | 0.0% |
| 2005 Q1 | -191.00 USD | -0.53% |
| 2005 FY | -308.03 Thousand USD | -40271.04% |
| 2005 Q4 | -307.45 Thousand USD | -160872.77% |
| 2005 Q2 | -191.00 USD | 0.0% |
| 2004 FY | -763.00 USD | 0.0% |
| 2004 Q2 | -191.00 USD | 0.0% |
| 2004 Q1 | -191.00 USD | 0.0% |
| 2004 Q3 | -191.00 USD | 0.0% |
| 2004 Q4 | -190.00 USD | 0.52% |
| 2003 FY | -763.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -112.605% |
| Alkermes plc | 414.12 Million USD | 221.779% |
| Agenus Inc. | -159.54 Million USD | -216.088% |
| Aptorum Group Limited | -10.52 Million USD | -4692.352% |
| Ardelyx, Inc. | -63.27 Million USD | -697.008% |
| Dyadic International, Inc. | -8.22 Million USD | -6027.959% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -42208.305% |
| Lantern Pharma Inc. | -17.87 Million USD | -2720.937% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2410.305% |
| Novavax, Inc. | -566.51 Million USD | 10.979% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -591.041% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -513.552% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2497.083% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4674.354% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -849.274% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -32.541% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1974.806% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1231.736% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -290.978% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -500.99% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2775.392% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1045.91% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1929.927% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -262.736% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -78.724% |
| AlloVir, Inc. | -181.33 Million USD | -178.118% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -146.005% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1623.682% |
| Bicycle Therapeutics plc | -189.94 Million USD | -165.504% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -193.578% |
| ChromaDex Corporation | -5.59 Million USD | -8907.233% |
| Chimerix, Inc. | -93.06 Million USD | -441.895% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1018.778% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -334.533% |
| CRISPR Therapeutics AG | -222.53 Million USD | -126.62% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1053.089% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -164.717% |
| Fortress Biotech, Inc. | -142.34 Million USD | -254.298% |
| Fortress Biotech, Inc. | -142.34 Million USD | -254.298% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -416.219% |
| ImmuCell Corporation | -5.74 Million USD | -8673.628% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -275.153% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3024.413% |
| Incyte Corporation | 620.52 Million USD | 181.272% |
| Innoviva, Inc. | 176.7 Million USD | 385.393% |
| IO Biotech, Inc. | -91.44 Million USD | -451.507% |
| Jaguar Health, Inc. | -34.29 Million USD | -1370.692% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -196.759% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4323.036% |
| ContextLogic Inc. | -328 Million USD | -53.755% |
| MiMedx Group, Inc. | 37.11 Million USD | 1458.754% |
| MEI Pharma, Inc. | 14.54 Million USD | 3567.989% |
| NextCure, Inc. | -67.63 Million USD | -645.62% |
| Onconetix, Inc. | -36.03 Million USD | -1299.53% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1108.983% |
| Opthea Limited | -191.84 Million USD | -162.879% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -18226.565% |
| Vaxcyte, Inc. | -468.04 Million USD | -7.75% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1071.593% |
| Precigen, Inc. | -88.92 Million USD | -467.137% |
| Pharming Group N.V. | -4.87 Million USD | -10235.29% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -201.422% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1594.835% |
| PureTech Health plc | -146.19 Million USD | -244.951% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2361.154% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -114.057% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1974.806% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -84.053% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1620.918% |
| Acelyrin, Inc. | -422.06 Million USD | -19.488% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3910852.668% |
| Summit Therapeutics Inc. | -89.73 Million USD | -461.999% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1260.66% |
| Senti Biosciences, Inc. | -92.72 Million USD | -443.871% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -339.402% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1009.726% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1371.722% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -12693.223% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -15849.241% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1427.255% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5832.42% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -641.683% |
| Seer, Inc. | -103.46 Million USD | -387.435% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -666.914% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -601.09% |
| ESSA Pharma Inc. | -32.13 Million USD | -1469.407% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1184.052% |
| GT Biopharma, Inc. | -13.57 Million USD | -3614.754% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -130.049% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -990.269% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 680.928% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -788.52% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -879.138% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4974.794% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -7211.032% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -894.841% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -94.222% |
| Aptose Biosciences Inc. | -52.35 Million USD | -863.242% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3397.142% |
| Soligenix, Inc. | -7.69 Million USD | -6451.298% |
| Century Therapeutics, Inc. | -146.54 Million USD | -244.134% |
| Kura Oncology, Inc. | -165.8 Million USD | -204.163% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -439.617% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5962.207% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -20221.852% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7677.838% |
| Autolus Therapeutics plc | -195.02 Million USD | -158.586% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -495.716% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -584.634% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2286.16% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -122.131% |
| GRI Bio, Inc. | -11.38 Million USD | -4328.866% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11067.999% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -284.407% |
| IGM Biosciences, Inc. | -263.46 Million USD | -91.419% |
| INmune Bio, Inc. | -29.74 Million USD | -1595.689% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -355.919% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1224.519% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3056.04% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3097.771% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -725.42% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -369.034% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -82.719% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -148.188% |
| Verastem, Inc. | -92.08 Million USD | -447.668% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -969.937% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -173.868% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -326.014% |
| Histogen Inc. | -10.64 Million USD | -4638.467% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3159.542% |
| Surrozen, Inc. | -45.78 Million USD | -1001.606% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3242.934% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9807.497% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -750.713% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -883.185% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1894.917% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -6507.171% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -194.434% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -940.942% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -544.863% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3213.333% |
| Apollomics, Inc. | -54.83 Million USD | -819.712% |
| Amarin Corporation plc | -67.58 Million USD | -646.161% |
| Mesoblast Limited | -58.79 Million USD | -757.766% |
| Turnstone Biologics Corp. | -59.03 Million USD | -754.308% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -204.667% |
| Synaptogenix, Inc. | -8.31 Million USD | -5965.959% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3357.528% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -450.016% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10425.276% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5610.583% |
| Exelixis, Inc. | 170.88 Million USD | 395.12% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1218.057% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -225.232% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 2.476% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4171.299% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -6171.088% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1581.442% |
| Gritstone bio, Inc. | -154.63 Million USD | -226.135% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -632.367% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2845.24% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2600.048% |
| Insmed Incorporated | -709.62 Million USD | 28.932% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3114.288% |
| MediWound Ltd. | -15.29 Million USD | -3198.332% |
| OmniAb, Inc. | -69.41 Million USD | -626.48% |
| Alector, Inc. | -151.74 Million USD | -232.355% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -367.032% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -867.084% |
| Zai Lab Limited | -366.57 Million USD | -37.576% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -59.202% |
| Aura Biosciences, Inc. | -84.99 Million USD | -493.375% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -105.424% |
| Immunic, Inc. | -99.22 Million USD | -408.264% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -252.279% |
| Veracyte, Inc. | -85.79 Million USD | -487.814% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -78.953% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3449.015% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -7221.703% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2583.58% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 187.164% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1881.358% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1399.714% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2544.216% |
| Galecto, Inc. | -39.9 Million USD | -1163.789% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1098.638% |
| Fortrea Holdings Inc. | 63.1 Million USD | 899.231% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -259.084% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1646.364% |
| XBiotech Inc. | -37.51 Million USD | -1244.481% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -632.367% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -651.363% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -367.365% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1864.455% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -846.324% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 11.401% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -542.505% |
| Vaxxinity, Inc. | -58.28 Million USD | -765.257% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -386.279% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2166.265% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -483.59% |
| NexImmune, Inc. | -29.19 Million USD | -1627.551% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -8873.366% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3358.624% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 112.461% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1880.891% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4204.911% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -296.905% |
| Ainos, Inc. | -13.2 Million USD | -3718.718% |
| Pluri Inc. | -22.15 Million USD | -2175.995% |
| Prothena Corporation plc | -191.03 Million USD | -163.99% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -265.345% |
| Celularity Inc. | -192.28 Million USD | -162.272% |
| Rallybio Corporation | -78.93 Million USD | -538.923% |
| Cue Biopharma, Inc. | -52.14 Million USD | -867.066% |
| MeiraGTx Holdings plc | -137.06 Million USD | -267.949% |
| Omeros Corporation | -164.53 Million USD | -206.519% |
| Humacyte, Inc. | -100.04 Million USD | -404.078% |
| Immunocore Holdings plc | -59.64 Million USD | -745.471% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2617.361% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1959.858% |
| Blueprint Medicines Corporation | -486.27 Million USD | -3.709% |
| CalciMedica, Inc. | -21.87 Million USD | -2205.44% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -575.482% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -283.553% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -194.413% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -54.272% |
| Pulmatrix, Inc. | -14.74 Million USD | -3321.404% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1310.869% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -467.501% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 2.13% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -646.569% |
| Cytokinetics, Incorporated | -496.2 Million USD | -1.634% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1365.223% |
| Nutriband Inc. | -4.87 Million USD | -10251.45% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1056.341% |
| Vor Biopharma Inc. | -126.03 Million USD | -300.136% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 111.889% |
| Evogene Ltd. | -26.39 Million USD | -1810.936% |
| ProKidney Corp. | -151.52 Million USD | -232.833% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -681.46% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -6456.151% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 16.967% |
| CorMedix Inc. | -48.95 Million USD | -930.102% |
| BioLineRx Ltd. | -49.69 Million USD | -914.841% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -341.711% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1224.635% |
| Atai Life Sciences N.V. | -125.47 Million USD | -301.937% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -517.736% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -519.483% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -102.546% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1540.582% |
| MediciNova, Inc. | -9.9 Million USD | -4993.955% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -299.069% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6863.312% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1785.787% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -117.541% |
| Biomea Fusion, Inc. | -126.13 Million USD | -299.822% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -44.337% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1674.757% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -163.916% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -119.311% |
| Absci Corporation | -115.51 Million USD | -336.58% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1728.089% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -346.822% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -108.255% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1901.568% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -142.466% |
| Allakos Inc. | -196.05 Million USD | -157.23% |
| Imunon, Inc. | -21.03 Million USD | -2298.025% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -355.717% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 570.084% |
| BioAtla, Inc. | -129.68 Million USD | -288.871% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4171.299% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3083.204% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -53.878% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1107.709% |
| XOMA Corporation | -41.84 Million USD | -1105.111% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -379.218% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -315.091% |
| aTyr Pharma, Inc. | -54.91 Million USD | -818.289% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -476.841% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -191.731% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -98.198% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2249.366% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -6040.631% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2900.803% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5702866.065% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 249.394% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7618.294% |
| UroGen Pharma Ltd. | -65.53 Million USD | -669.524% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -464.882% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6843.607% |
| Orgenesis Inc. | -53.63 Million USD | -840.255% |
| Entera Bio Ltd. | -8.89 Million USD | -5572.197% |
| GH Research PLC | -41.22 Million USD | -1123.412% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1861.705% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -507.221% |
| Xencor, Inc. | -138.63 Million USD | -263.761% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -9683.818% |
| Replimune Group, Inc. | -234.77 Million USD | -114.81% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2246.62% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3514.643% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7618.294% |
| Portage Biotech Inc. | -18.25 Million USD | -2662.916% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6863.312% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -380.478% |
| OncoCyte Corporation | -25.13 Million USD | -1906.345% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4361.047% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4301.783% |
| Purple Biotech Ltd. | 22.27 Million USD | 2364.447% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6613.458% |
| scPharmaceuticals Inc. | -55.39 Million USD | -810.382% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2568.659% |
| HilleVax, Inc. | -133.34 Million USD | -278.203% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4085.534% |
| Tharimmune, Inc. | -9.45 Million USD | -5233.72% |
| Genprex, Inc. | -31.07 Million USD | -1522.866% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -167.976% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1507.276% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -65823.529% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -9158.72% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3201954.892% |
| Savara Inc. | -60 Million USD | -740.427% |
| Curis, Inc. | -48.33 Million USD | -943.439% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1535.269% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -9566.244% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6830.26% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1750.697% |
| BeiGene, Ltd. | -1.2 Billion USD | 58.243% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2429.251% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -3.516% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -438.499% |
| Erasca, Inc. | -141.52 Million USD | -256.343% |
| bluebird bio, Inc. | -244.26 Million USD | -106.465% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -11040.223% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 359.367% |
| DBV Technologies S.A. | -76.43 Million USD | -559.822% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -11040.223% |
| Moderna, Inc. | -4.23 Billion USD | 88.103% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1083.588% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -7829.481% |
| Molecular Templates, Inc. | -10.46 Million USD | -4718.603% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -650.056% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -33.861% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -251.903% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -869.967% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -226.329% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -142.308% |
| MacroGenics, Inc. | -168.24 Million USD | -199.752% |
| RenovoRx, Inc. | -11.39 Million USD | -4325.369% |
| Adicet Bio, Inc. | -152.03 Million USD | -231.703% |
| Prime Medicine, Inc. | -191.29 Million USD | -163.636% |
| Aditxt, Inc. | -26.06 Million USD | -1835.027% |
| Adagene Inc. | -23.71 Million USD | -2026.129% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6798.882% |
| Quantum-Si incorporated | -111.17 Million USD | -353.639% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1493.513% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3359.48% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 513.326% |
| SciSparc Ltd. | -5.77 Million USD | -8635.753% |
| Vericel Corporation | -6.46 Million USD | -7701.903% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5725.743% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2081.333% |
| Generation Bio Co. | -138.56 Million USD | -263.961% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -507.389% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -483.293% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -109.172% |
| Invivyd, Inc. | -207.78 Million USD | -142.712% |
| Relay Therapeutics, Inc. | -373 Million USD | -35.205% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5277.35% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2447.726% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4802.45% |
| 2seventy bio, Inc. | -216.7 Million USD | -132.722% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2431.338% |
| Clene Inc. | -40.54 Million USD | -1143.994% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1994.518% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -820.35% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1785.787% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -44.065% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1272.958% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3236.873% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -386.312% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1383.192% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -196.172% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 26.303% |
| Evaxion Biotech A/S | -22.19 Million USD | -2171.996% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -512.166% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -126.025% |
| Trevena, Inc. | -35.28 Million USD | -1329.14% |
| Surrozen, Inc. | -45.78 Million USD | -1001.606% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -530.827% |
| Cingulate Inc. | -22.75 Million USD | -2115.874% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6831.38% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1029.055% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -6024.831% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -391.736% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -587.274% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -712.442% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5669.303% |
| Kronos Bio, Inc. | -121.83 Million USD | -313.95% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -561.865% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -17094.599% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -400.179% |
| Statera Biopharma, Inc. | -98.34 Million USD | -412.808% |
| ImmunityBio, Inc. | -362.25 Million USD | -39.217% |
| Korro Bio, Inc. | -84.53 Million USD | -496.582% |
| Kineta, Inc. | -15.72 Million USD | -3107.499% |
| BioVie Inc. | -32.17 Million USD | -1467.189% |
| Codexis, Inc. | -68.06 Million USD | -640.888% |
| Celularity Inc. | -192.28 Million USD | -162.272% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -126.548% |
| Celcuity Inc. | -66.23 Million USD | -661.456% |
| Virax Biolabs Group Limited | -6.49 Million USD | -7662.905% |
| Cibus, Inc. | -318.88 Million USD | -58.15% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1072.826% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1390.116% |
| IN8bio, Inc. | -30.33 Million USD | -1562.376% |
| Kodiak Sciences Inc. | -277.32 Million USD | -81.852% |
| Annexon, Inc. | -143.72 Million USD | -250.894% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -307.392% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -680.118% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2051.147% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -42.571% |
| Eyenovia, Inc. | -25.4 Million USD | -1884.988% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1645.083% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8967.152% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -537.3% |
| Arcellx, Inc. | -89.88 Million USD | -461.098% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1010.532% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -267.558% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1521.123% |
| Moolec Science SA | -6.65 Million USD | -7479.347% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -724.88% |
| Geron Corporation | -193.94 Million USD | -160.031% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1065.965% |
| Royalty Pharma plc | 1.49 Billion USD | 133.798% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -207.206% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5306.542% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2203.37% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -194.995% |
| Humacyte, Inc. | -100.04 Million USD | -404.078% |
| Structure Therapeutics Inc. | -102.77 Million USD | -390.698% |
| 89bio, Inc. | -151.2 Million USD | -233.533% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -529.355% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3368.466% |
| Genelux Corporation | -24.16 Million USD | -1986.965% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1386.646% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -193.633% |
| Notable Labs, Ltd. | -14.65 Million USD | -3340.779% |
| Liquidia Corporation | -73.38 Million USD | -587.227% |
| Mustang Bio, Inc. | -50.72 Million USD | -894.194% |
| Immunovant, Inc. | -282.7 Million USD | -78.387% |
| Quantum-Si incorporated | -111.17 Million USD | -353.639% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -545.705% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2271.35% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -394.368% |
| Acasti Pharma Inc. | -11.31 Million USD | -4358.23% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2100.221% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3056.04% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -135.602% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -13645.029% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3074.588% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1629.653% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1118.623% |
| PepGen Inc. | -84.76 Million USD | -494.95% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1601.984% |
| United Therapeutics Corporation | 1.18 Billion USD | 142.562% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2102.537% |
| Solid Biosciences Inc. | -104.31 Million USD | -383.454% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1437.165% |
| Immuneering Corporation | -58.41 Million USD | -763.363% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -9807.497% |
| Silo Pharma, Inc. | -3.85 Million USD | -12980.092% |
| Belite Bio, Inc | -31.66 Million USD | -1492.507% |
| XOMA Corporation | -41.84 Million USD | -1105.111% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -646.912% |
| Bionomics Limited | -17.89 Billion USD | 97.181% |
| Apogee Therapeutics, Inc. | -93 Million USD | -442.257% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1513.439% |
| uniQure N.V. | -282.87 Million USD | -78.284% |
| Cassava Sciences, Inc. | -105.95 Million USD | -375.962% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6798.882% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -289.42% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1452.407% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5969.682% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1615.649% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -8967.152% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3449.015% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5573.473% |
| Altimmune, Inc. | -95.92 Million USD | -425.717% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -586.199% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1513.439% |
| Compugen Ltd. | -12.99 Million USD | -3781.735% |
| Peak Bio, Inc. | -1356.23 USD | -37184964.48% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -916.682% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2142.397% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -108.134% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1595.404% |
| Zura Bio Limited | -62.63 Million USD | -705.126% |
| PolyPid Ltd. | -22.86 Million USD | -2105.427% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2998.519% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1595.404% |
| Instil Bio, Inc. | -159.16 Million USD | -216.842% |
| argenx SE | -425.04 Million USD | -18.649% |
| Immunome, Inc. | -109.53 Million USD | -360.435% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -901.36% |
| Verona Pharma plc | -67.83 Million USD | -643.489% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1835.207% |
| Shattuck Labs, Inc. | -91.95 Million USD | -448.425% |
| CervoMed Inc. | -7.81 Million USD | -6354.906% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -589.803% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3685.864% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -946.861% |
| Moolec Science SA | -6.65 Million USD | -7479.347% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2966.035% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -272.941% |
| AnaptysBio, Inc. | -164.41 Million USD | -206.74% |
| Design Therapeutics, Inc. | -78.19 Million USD | -544.987% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -479.399% |
| NeurAxis, Inc. | -6.66 Million USD | -7467.19% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1145.253% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1277.383% |
| Achilles Therapeutics plc | -75.25 Million USD | -570.142% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1835.207% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3641.903% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 9880.539% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -17094.599% |
| Nutriband Inc. | -4.87 Million USD | -10251.45% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -355.24% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -809.511% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -892.043% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -662.969% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -831.793% |
| Palisade Bio, Inc. | -13.07 Million USD | -3758.569% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1010.606% |
| Beam Therapeutics Inc. | -176.48 Million USD | -185.755% |
| Neurogene Inc. | -55.58 Million USD | -807.319% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -362.022% |
| AEON Biopharma, Inc. | -48.42 Million USD | -941.349% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -421.471% |
| Sesen Bio, Inc. | -25.9 Million USD | -1846.486% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -503.76% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3906.667% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -9.501% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -596.193% |
| Athira Pharma, Inc. | -125.46 Million USD | -301.954% |
| Vaccinex, Inc. | -22.88 Million USD | -2103.692% |
| HCW Biologics Inc. | -25.71 Million USD | -1861.006% |
| XOMA Corporation | -41.84 Million USD | -1105.111% |
| Nektar Therapeutics | -137.42 Million USD | -266.975% |
| Arvinas, Inc. | -401.5 Million USD | -25.608% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5702866.065% |
| Merus N.V. | -156.54 Million USD | -222.149% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -403.002% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1356.716% |
| Rezolute, Inc. | -70.42 Million USD | -616.123% |
| Clene Inc. | -40.54 Million USD | -1143.994% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2979.133% |
| BeyondSpring Inc. | -23.11 Million USD | -2081.859% |
| Synlogic, Inc. | -55.16 Million USD | -814.26% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2712.845% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4559.229% |
| Peak Bio, Inc. | -1356.23 USD | -37184964.48% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1145.13% |
| Krystal Biotech, Inc. | -109.72 Million USD | -359.609% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -289.312% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -47.025% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -10526.211% |
| MannKind Corporation | 8.67 Million USD | 5911.42% |
| Ikena Oncology, Inc. | -75.41 Million USD | -568.702% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5127.687% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -650.134% |
| Gossamer Bio, Inc. | -183.75 Million USD | -174.444% |
| CohBar, Inc. | -12.38 Million USD | -3970.899% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -894.233% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1728.089% |
| Legend Biotech Corporation | -439.48 Million USD | -14.751% |
| Mural Oncology plc | -194.63 Million USD | -159.104% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -651.106% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3023.608% |
| Disc Medicine, Inc. | -91.12 Million USD | -453.432% |
| Champions Oncology, Inc. | -7.35 Million USD | -6755.832% |
| REGENXBIO Inc. | -268.12 Million USD | -88.087% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4605.227% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -804.504% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1194.422% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -341.001% |
| Vaxart, Inc. | -83.34 Million USD | -505.079% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5819.185% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1078.469% |
| Cellectis S.A. | -106.62 Million USD | -372.976% |
| Longeveron Inc. | -21.02 Million USD | -2298.188% |
| Repare Therapeutics Inc. | -116.22 Million USD | -333.916% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -88.301% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -566.686% |
| Revolution Medicines, Inc. | -487.18 Million USD | -3.516% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -7481.404% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1047.37% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -576.116% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -624.226% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4480.102% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 111.708% |
| Denali Therapeutics Inc. | -196.69 Million USD | -156.389% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5725.743% |
| Veru Inc. | -93.78 Million USD | -437.751% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2061.751% |
| Cingulate Inc. | -22.75 Million USD | -2115.874% |
| Passage Bio, Inc. | -108.38 Million USD | -365.282% |
| Context Therapeutics Inc. | -25.07 Million USD | -1911.418% |
| Exicure, Inc. | -14.99 Million USD | -3262.997% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -144.737% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1142.216% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5090.061% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -173.553% |
| Nuvalent, Inc. | -149.49 Million USD | -237.353% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -6037.826% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -468.364% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2327.626% |
| OmniAb, Inc. | -69.41 Million USD | -626.48% |
| Anew Medical, Inc. | -1.3 Million USD | -38668.411% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3848.908% |
| Lipocine Inc. | -17.93 Million USD | -2712.538% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -636.087% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -562.248% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1224.519% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1175.875% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2153.016% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 13.026% |
| Ocugen, Inc. | -65.53 Million USD | -669.582% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -437.271% |
| Q32 Bio Inc. | -92.1 Million USD | -447.561% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2252.325% |
| Alumis Inc. Common Stock | -158.17 Million USD | -218.836% |
| Equillium, Inc. | -14.52 Million USD | -3372.765% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -708.119% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6281.029% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2573.269% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -974.13% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -364.952% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4113.153% |
| Dominari Holdings Inc. | -21.79 Million USD | -2213.796% |
| Edesa Biotech, Inc. | -9.22 Million USD | -5368.158% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1877.551% |
| Bio-Techne Corporation | 206.68 Million USD | 344.001% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -28.82% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 362.623% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -281.257% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1213.628% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -233.76% |
| Nkarta, Inc. | -131.65 Million USD | -283.073% |
| BioCardia, Inc. | -11.64 Million USD | -4231.115% |
| Iterum Therapeutics plc | -47.46 Million USD | -962.432% |